GLP-1 Drugs Show Promise in Reducing Alcohol Cravings and Use
The article discusses emerging evidence that GLP-1 therapeutics, like tirzepatide and retatrutide, may reduce addictive behaviors beyond weight loss, potentially by influencing brain energy and reward systems, and questions traditional notions of addiction and character traits like grit.